Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PRMT5 is a therapeutic target in choroidal neovascularization.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PRMT5 is a therapeutic target in choroidal neovascularization.
PRMT5 is a therapeutic target in choroidal neovascularization. Sci Rep. 2023 01 31; 13(1):1747.
View in:
PubMed
subject areas
Animals
Choroidal Neovascularization
Endothelial Cells
Humans
Mice
NF-kappa B
Pancreatic Neoplasms
Protein-Arginine N-Methyltransferases
Retina
Vascular Endothelial Growth Factor A
authors with profiles
Nathan Robert Jensen